BioPharma Credit PLC

BOPCFOTCFinancial Services● Active

$0.91

+$0.91(+82064.72%)

Market Cap$1.0B

P/E Ratio—

52W High$1.02

52W Low$0.8364

Avg Volume383K

Open$0.94

Beta0.18

Net Income Financials Revenue

BioPharma Credit PLC (BOPCF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BOPCF · net income · updated Jun 8, 2026

Core profitability metrics

BOPCF · net income · margin · TTM · CAGR

Net income was $129.9M for FY2025 (fiscal year ending 2025-12-31), up 6.3% year-over-year. Net profit margin was 92.6%. Based on available data, BioPharma Credit PLC has been profitable since at least 2017.

FY2025 Net Income$129.9M▲ +6.3% YoY

Trailing 12M (TTM)$252.1Mtrailing 4 quarters sum

Net Profit Margin92.6%$129.9M ÷ $140.2M

YoY Change+6.3%—

5-Year CAGR+7.8%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2017

▸ FMP /income-statement · Annual · BOPCF net income history · BOPCF profit margin

Annual net income data

BOPCF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$129.9M▲ +6.3%92.6%$140.2M

FY2024$122.2M▲ +12.7%98.2%$124.5M

FY2023$108.5M▼ 40.5%79.9%$135.7M

FY2022$182.3M▲ +114.6%99.0%$184.2M

FY2021$85.0M▼ 4.7%96.6%$88.0M

Net income vs peers (Financial Services)

BOPCF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

BioPharma Credit PLCYOU

BOPCF

$129.9M+6.3%92.6%

Berkshire Hathaway Inc.

BRK-B

$66.97B-24.8%18.0%

100%

Berkshire Hathaway Inc.

Mastercard Incorporated

$14.97B+16.3%45.6%

22%

Financial Services · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

BioPharma Credit PLC (BOPCF) reported net income of $129.9M for FY2025 (fiscal year ending 2025-12-31), up 6.3% year-over-year. The net profit margin was 92.6% — meaning the company kept $0.93 of every dollar of revenue as profit.

Based on available data, BioPharma Credit PLC has been profitable since at least 2017. Net income reached a peak of $182.3M in FY2022. Data available for 9 fiscal years.

BioPharma Credit PLC's net profit margin was 92.6% for FY2025, based on the latest annual results.

Investors sometimes search for "BioPharma Credit PLC net worth" — the company's market capitalization is a separate figure from BOPCF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BOPCF net income · 5 questions

BioPharma Credit PLC is profitable. The company reported net income of $129.9M for FY2025, a net profit margin of 92.6%. Net income was up 6.3% year-over-year. Based on available data, BioPharma Credit PLC has been profitable since at least 2017.

is BOPCF profitabledoes BOPCF make a profitBOPCF profitabilityBOPCF profitable company

▸ Source: FMP /income-statement · GAAP · BioPharma Credit PLC · BioPharma Credit PLC SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026